Skip to main content
main-content
Top

Tip

Swipe om te navigeren naar een ander artikel

Gepubliceerd in: Quality of Life Research 10/2010

01-12-2010

Biological pathways and genetic variables involved in pain

Auteurs: Qiuling Shi, Charles S. Cleeland, Pål Klepstad, Christine Miaskowski, Nancy L. Pedersen

Gepubliceerd in: Quality of Life Research | Uitgave 10/2010

Log in om toegang te krijgen
share
DELEN

Deel dit onderdeel of sectie (kopieer de link)

  • Optie A:
    Klik op de rechtermuisknop op de link en selecteer de optie “linkadres kopiëren”
  • Optie B:
    Deel de link per e-mail

Abstract

Purpose

This paper summarizes current knowledge of pain-related and analgesic-related pathways as well as genetic variations involved in pain perception and management.

Methods

The pain group of the GENEQOL Consortium was given the task of summarizing the current status of research on genetic variations in pain and analgesic efficacy. This review is neither exhaustive nor comprehensive; we focus primarily on single-nucleotide polymorphisms.

Results

Two categories of potential genetic pain-perception pathways were identified: neurotransmission modulators and mechanisms that affect inflammation. Four categories were identified for analgesic efficacy: genes related to receptor interaction, modulation of opioid effects, metabolism, and transport. Various genetic variations involved in these pathways are proposed as candidate genetic markers for pain perception and for individual sensitivity to analgesics.

Conclusions

Candidate gene association studies have been used to provide evidence for the genetic modulation of pain perception and response to analgesics. However, the nature and range of genetic modulation of pain is not well addressed due to the limited number of patients and the limited number of genes and genetic variants investigated in studies to date. Moreover, personalized analgesic treatments will require a more complete understanding of the effects of genetic variants and gene–gene interactions in response to analgesics.
Woordenlijst
Allele
One of various forms of a gene, usually referring to a specific genetic locus
Allodynia
Pain produced by a stimulus that does not normally provoke pain, i.e., pressure from clothing or simple touch
Base
The essential basic component of DNA or RNA. There are four DNA bases: adenine (A), guanine (G), thymine (T), and cytosine (C)
Candidate gene association study
A method that determines whether a particular form of a DNA polymorphism occurs more frequently in subjects with a phenotype of interest, usually focusing on genes involved in the biological pathways of disease development and treatment
Chromosome
Thread-like structures of DNA found in the nucleus of a cell that carry hereditary information
Genome
The entire hereditary information of an organism
Genome-wide association study
A method to examine genetic variation across a given genome, designed to identify genetic associations with phenotypes of interest, usually 1,000,000 or more markers involved
Genotype
Instructions of the internal inheritable information of any living organism
Haplotype
A set of genetic markers in the same chromosome that highly correlate to each other and tend to be inherited together
Heterozygote
An organism with two different alleles at one gene location
Homozygote
An organism with two identical alleles at one gene location
Hyperalgesia
Increased pain sensitivity, usually abnormal
Nociception
Perception of pain
Nonsynonymous SNP
A DNA base change that results in an altered polypeptide sequence
Phenotype
Anything that is part of the observable structure, function, or behavior of a living organism
Polymorphism
Variety in forms of a particular DNA sequence in a population
SNP
Short form for single-nucleotide polymorphism, a variation between individuals in a single nucleotide (A, T, C, or G) of the DNA sequence
Literatuur
1.
go back to reference Aubrun, F., Langeron, O., Quesnel, C., Coriat, P., & Riou, B. (2003). Relationships between measurement of pain using visual analog score and morphine requirements during postoperative intravenous morphine titration. Anesthesiology, 98(6), 1415–1421. PubMedCrossRef Aubrun, F., Langeron, O., Quesnel, C., Coriat, P., & Riou, B. (2003). Relationships between measurement of pain using visual analog score and morphine requirements during postoperative intravenous morphine titration. Anesthesiology, 98(6), 1415–1421. PubMedCrossRef
2.
go back to reference Klepstad, P., Dale, O., Kaasa, S., Zahlsen, K., Aamo, T., Fayers, P., et al. (2003). Influences on serum concentrations of morphine, M6G and M3G during routine clinical drug monitoring: a prospective survey in 300 adult cancer patients. Acta Anaesthesiologica Scandinavica, 47(6), 725–731. PubMedCrossRef Klepstad, P., Dale, O., Kaasa, S., Zahlsen, K., Aamo, T., Fayers, P., et al. (2003). Influences on serum concentrations of morphine, M6G and M3G during routine clinical drug monitoring: a prospective survey in 300 adult cancer patients. Acta Anaesthesiologica Scandinavica, 47(6), 725–731. PubMedCrossRef
3.
go back to reference Sprangers, M. A., Sloan, J. A., Veenhoven, R., Cleeland, C. S., Halyard, M. Y., Abertnethy, A. P., et al. (2009). The establishment of the GENEQOL consortium to investigate the genetic disposition of patient-reported quality-of-life outcomes. Twin Research and Human Genetics, 12(3), 301–311. PubMedCrossRef Sprangers, M. A., Sloan, J. A., Veenhoven, R., Cleeland, C. S., Halyard, M. Y., Abertnethy, A. P., et al. (2009). The establishment of the GENEQOL consortium to investigate the genetic disposition of patient-reported quality-of-life outcomes. Twin Research and Human Genetics, 12(3), 301–311. PubMedCrossRef
4.
go back to reference Lotta, T., Vidgren, J., Tilgmann, C., Ulmanen, I., Melén, K., Julkunen, I., et al. (1995). Kinetics of human soluble and membrane-bound catechol O-methyltransferase: A revised mechanism and description of the thermolabile variant of the enzyme. Biochemistry, 34(13), 4202–4210. PubMedCrossRef Lotta, T., Vidgren, J., Tilgmann, C., Ulmanen, I., Melén, K., Julkunen, I., et al. (1995). Kinetics of human soluble and membrane-bound catechol O-methyltransferase: A revised mechanism and description of the thermolabile variant of the enzyme. Biochemistry, 34(13), 4202–4210. PubMedCrossRef
5.
go back to reference Zubieta, J. K., Heitzeg, M. M., Smith, Y. R., Bueller, J. A., Xu, K., Xu, Y., et al. (2003). COMT val158met genotype affects mu-opioid neurotransmitter responses to a pain stressor. Science, 299(5610), 1240–1243. PubMedCrossRef Zubieta, J. K., Heitzeg, M. M., Smith, Y. R., Bueller, J. A., Xu, K., Xu, Y., et al. (2003). COMT val158met genotype affects mu-opioid neurotransmitter responses to a pain stressor. Science, 299(5610), 1240–1243. PubMedCrossRef
6.
go back to reference Nackley, A. G., Shabalina, S. A., Tchivileva, I. E., Satterfield, K., Korchynskyi, O., Makarov, S. S., et al. (2006). Human catechol-O-methyltransferase haplotypes modulate protein expression by altering mRNA secondary structure. Science, 314(5807), 1930–1933. PubMedCrossRef Nackley, A. G., Shabalina, S. A., Tchivileva, I. E., Satterfield, K., Korchynskyi, O., Makarov, S. S., et al. (2006). Human catechol-O-methyltransferase haplotypes modulate protein expression by altering mRNA secondary structure. Science, 314(5807), 1930–1933. PubMedCrossRef
7.
go back to reference Diatchenko, L., Slade, G. D., Nackley, A. G., Bhalang, K., Sigurdsson, A., Belfer, I., et al. (2005). Genetic basis for individual variations in pain perception and the development of a chronic pain condition. Human Molecular Genetics, 14(1), 135–143. PubMedCrossRef Diatchenko, L., Slade, G. D., Nackley, A. G., Bhalang, K., Sigurdsson, A., Belfer, I., et al. (2005). Genetic basis for individual variations in pain perception and the development of a chronic pain condition. Human Molecular Genetics, 14(1), 135–143. PubMedCrossRef
8.
go back to reference Rakvåg, T. T., Ross, J. R., Sato, H., Skorpen, F., Kaasa, S., & Klepstad, P. (2008). Genetic variation in the catechol-O-methyltransferase (COMT) gene and morphine requirements in cancer patients with pain. Molecular Pain, 4, 64. PubMed Rakvåg, T. T., Ross, J. R., Sato, H., Skorpen, F., Kaasa, S., & Klepstad, P. (2008). Genetic variation in the catechol-O-methyltransferase (COMT) gene and morphine requirements in cancer patients with pain. Molecular Pain, 4, 64. PubMed
9.
go back to reference Ross, J. R., Riley, J., Taegetmeyer, A. B., Sato, H., Gretton, S., du Bois, R. M., et al. (2008). Genetic variation and response to morphine in cancer patients: Catechol-O-methyltransferase and multidrug resistance-1 gene polymorphisms are associated with central side effects. Cancer, 112(6), 1390–1403. PubMedCrossRef Ross, J. R., Riley, J., Taegetmeyer, A. B., Sato, H., Gretton, S., du Bois, R. M., et al. (2008). Genetic variation and response to morphine in cancer patients: Catechol-O-methyltransferase and multidrug resistance-1 gene polymorphisms are associated with central side effects. Cancer, 112(6), 1390–1403. PubMedCrossRef
10.
go back to reference Pert, C. B., & Snyder, S. H. (1973). Opiate receptor: Demonstration in nervous tissue. Science, 179(77), 1011–1014. PubMedCrossRef Pert, C. B., & Snyder, S. H. (1973). Opiate receptor: Demonstration in nervous tissue. Science, 179(77), 1011–1014. PubMedCrossRef
11.
go back to reference Stein, C. (1993). Peripheral mechanisms of opioid analgesia. Anesthesia and Analgesia, 76(1), 182–191. PubMedCrossRef Stein, C. (1993). Peripheral mechanisms of opioid analgesia. Anesthesia and Analgesia, 76(1), 182–191. PubMedCrossRef
12.
go back to reference Bidlack, J. M., Khimich, M., Parkhill, A. L., Sumagin, S., Sun, B., & Tipton, C. M. (2006). Opioid receptors and signaling on cells from the immune system. Journal of Neuroimmune Pharmacology, 1(3), 260–269. PubMedCrossRef Bidlack, J. M., Khimich, M., Parkhill, A. L., Sumagin, S., Sun, B., & Tipton, C. M. (2006). Opioid receptors and signaling on cells from the immune system. Journal of Neuroimmune Pharmacology, 1(3), 260–269. PubMedCrossRef
14.
go back to reference Satoh, M., & Minami, M. (1995). Molecular pharmacology of the opioid receptors. Pharmacology and Therapeutics, 68(3), 343–364. PubMedCrossRef Satoh, M., & Minami, M. (1995). Molecular pharmacology of the opioid receptors. Pharmacology and Therapeutics, 68(3), 343–364. PubMedCrossRef
15.
go back to reference Bond, C., LaForge, K. S., Tian, M., Melia, D., Zhang, S., Borg, L., et al. (1998). Single-nucleotide polymorphism in the human mu opioid receptor gene alters beta-endorphin binding and activity: Possible implications for opiate addiction. Proceedings of the National Academy of Sciences of the United States of America, 95(16), 9608–9613. PubMedCrossRef Bond, C., LaForge, K. S., Tian, M., Melia, D., Zhang, S., Borg, L., et al. (1998). Single-nucleotide polymorphism in the human mu opioid receptor gene alters beta-endorphin binding and activity: Possible implications for opiate addiction. Proceedings of the National Academy of Sciences of the United States of America, 95(16), 9608–9613. PubMedCrossRef
16.
go back to reference Oertel, B. G., Kettner, M., Scholich, K., Renné, C., Roskam, B., Geisslinger, G., et al. (2009). A common human {micro}-opioid receptor genetic variant diminishes the receptor signaling efficacy in brain regions processing the sensory information of pain. The Journal of Biological Chemistry, 284(10), 6530–6535. PubMedCrossRef Oertel, B. G., Kettner, M., Scholich, K., Renné, C., Roskam, B., Geisslinger, G., et al. (2009). A common human {micro}-opioid receptor genetic variant diminishes the receptor signaling efficacy in brain regions processing the sensory information of pain. The Journal of Biological Chemistry, 284(10), 6530–6535. PubMedCrossRef
17.
go back to reference Sia, A. T., Lim, Y., Lim, E. C., Goh, R. W., Law, H. Y., Landau, R., et al. (2008). A118G single nucleotide polymorphism of human mu-opioid receptor gene influences pain perception and patient-controlled intravenous morphine consumption after intrathecal morphine for postcesarean analgesia. Anesthesiology, 109(3), 520–526. PubMedCrossRef Sia, A. T., Lim, Y., Lim, E. C., Goh, R. W., Law, H. Y., Landau, R., et al. (2008). A118G single nucleotide polymorphism of human mu-opioid receptor gene influences pain perception and patient-controlled intravenous morphine consumption after intrathecal morphine for postcesarean analgesia. Anesthesiology, 109(3), 520–526. PubMedCrossRef
18.
go back to reference Chou, W. Y., Wang, C. H., Liu, P. H., Liu, C. C., Tseng, C. C., & Jawan, B. (2006). Human opioid receptor A118G polymorphism affects intravenous patient-controlled analgesia morphine consumption after total abdominal hysterectomy. Anesthesiology, 105(2), 334–337. PubMedCrossRef Chou, W. Y., Wang, C. H., Liu, P. H., Liu, C. C., Tseng, C. C., & Jawan, B. (2006). Human opioid receptor A118G polymorphism affects intravenous patient-controlled analgesia morphine consumption after total abdominal hysterectomy. Anesthesiology, 105(2), 334–337. PubMedCrossRef
19.
go back to reference Klepstad, P., Rakvåg, T. T., Kaasa, S., Holthe, M., Dale, O., Borchgrevink, P. C., et al. (2004). The 118 A>G polymorphism in the human mu-opioid receptor gene may increase morphine requirements in patients with pain caused by malignant disease. Acta Anaesthesiologica Scandinavica, 48(10), 1232–1239. PubMedCrossRef Klepstad, P., Rakvåg, T. T., Kaasa, S., Holthe, M., Dale, O., Borchgrevink, P. C., et al. (2004). The 118 A>G polymorphism in the human mu-opioid receptor gene may increase morphine requirements in patients with pain caused by malignant disease. Acta Anaesthesiologica Scandinavica, 48(10), 1232–1239. PubMedCrossRef
20.
go back to reference Landau, R., Kern, C., Columb, M. O., Smiley, R. M., & Blouin, J. L. (2008). Genetic variability of the mu-opioid receptor influences intrathecal fentanyl analgesia requirements in laboring women. Pain, 139(1), 5–14. PubMedCrossRef Landau, R., Kern, C., Columb, M. O., Smiley, R. M., & Blouin, J. L. (2008). Genetic variability of the mu-opioid receptor influences intrathecal fentanyl analgesia requirements in laboring women. Pain, 139(1), 5–14. PubMedCrossRef
21.
go back to reference Blakely, R. D., De Felice, L. J., & Hartzell, H. C. (1994). Molecular physiology of norepinephrine and serotonin transporters. Journal of Experimental Biology, 196, 263–281. PubMed Blakely, R. D., De Felice, L. J., & Hartzell, H. C. (1994). Molecular physiology of norepinephrine and serotonin transporters. Journal of Experimental Biology, 196, 263–281. PubMed
22.
go back to reference Lesch, K. P., Bengel, D., Heils, A., Sabol, S. Z., Greenberg, B. D., Petri, S., et al. (1996). Association of anxiety-related traits with a polymorphism in the serotonin transporter gene regulatory region. Science, 274(5292), 1527–1531. PubMedCrossRef Lesch, K. P., Bengel, D., Heils, A., Sabol, S. Z., Greenberg, B. D., Petri, S., et al. (1996). Association of anxiety-related traits with a polymorphism in the serotonin transporter gene regulatory region. Science, 274(5292), 1527–1531. PubMedCrossRef
23.
go back to reference Heils, A., Teufel, A., Petri, S., Stöber, G., Riederer, P., Bengel, D., et al. (1996). Allelic variation of human serotonin transporter gene expression. Journal of Neurochemistry, 66(6), 2621–2624. PubMedCrossRef Heils, A., Teufel, A., Petri, S., Stöber, G., Riederer, P., Bengel, D., et al. (1996). Allelic variation of human serotonin transporter gene expression. Journal of Neurochemistry, 66(6), 2621–2624. PubMedCrossRef
24.
go back to reference Kosek, E., Jensen, K. B., Lonsdorf, T. B., Schalling, M., & Ingvar, M. (2009). Genetic variation in the serotonin transporter gene (5-HTTLPR, rs25531) influences the analgesic response to the short acting opioid Remifentanil in humans. Molecular pain, 5, 37. PubMedCrossRef Kosek, E., Jensen, K. B., Lonsdorf, T. B., Schalling, M., & Ingvar, M. (2009). Genetic variation in the serotonin transporter gene (5-HTTLPR, rs25531) influences the analgesic response to the short acting opioid Remifentanil in humans. Molecular pain, 5, 37. PubMedCrossRef
25.
go back to reference Herken, H., Erdal, E., Mutlu, N., Barlas, O., Cataloluk, O., Oz, F., et al. (2001). Possible association of temporomandibular joint pain and dysfunction with a polymorphism in the serotonin transporter gene. American Journal of Orthodontics and Dentofacial Orthopedics, 120(3), 308–313. PubMedCrossRef Herken, H., Erdal, E., Mutlu, N., Barlas, O., Cataloluk, O., Oz, F., et al. (2001). Possible association of temporomandibular joint pain and dysfunction with a polymorphism in the serotonin transporter gene. American Journal of Orthodontics and Dentofacial Orthopedics, 120(3), 308–313. PubMedCrossRef
26.
go back to reference Tegeder, I., Costigan, M., Griffin, R. S., Abele, A., Belfer, I., Schmidt, H., et al. (2006). GTP cyclohydrolase and tetrahydrobiopterin regulate pain sensitivity and persistence. Nature Medicine, 12(11), 1269–1277. PubMedCrossRef Tegeder, I., Costigan, M., Griffin, R. S., Abele, A., Belfer, I., Schmidt, H., et al. (2006). GTP cyclohydrolase and tetrahydrobiopterin regulate pain sensitivity and persistence. Nature Medicine, 12(11), 1269–1277. PubMedCrossRef
27.
go back to reference Lötsch, J., Belfer, I., Kirchhof, A., Mishra, B. K., Max, M. B., Doehring, A., et al. (2007). Reliable screening for a pain-protective haplotype in the GTP cyclohydrolase 1 gene (GCH1) through the use of 3 or fewer single nucleotide polymorphisms. Clinical Chemistry, 53(6), 1010–1015. PubMedCrossRef Lötsch, J., Belfer, I., Kirchhof, A., Mishra, B. K., Max, M. B., Doehring, A., et al. (2007). Reliable screening for a pain-protective haplotype in the GTP cyclohydrolase 1 gene (GCH1) through the use of 3 or fewer single nucleotide polymorphisms. Clinical Chemistry, 53(6), 1010–1015. PubMedCrossRef
28.
go back to reference Story, G. M., Peier, A. M., Reeve, A. J., Eid, S. R., Mosbacher, J., Hricik, T. R., et al. (2003). ANKTM1, a TRP-like channel expressed in nociceptive neurons, is activated by cold temperatures. Cell, 112(6), 819–829. PubMedCrossRef Story, G. M., Peier, A. M., Reeve, A. J., Eid, S. R., Mosbacher, J., Hricik, T. R., et al. (2003). ANKTM1, a TRP-like channel expressed in nociceptive neurons, is activated by cold temperatures. Cell, 112(6), 819–829. PubMedCrossRef
29.
go back to reference Kim, H., Mittal, D. P., Iadarola, M. J., & Dionne, R. A. (2006). Genetic predictors for acute experimental cold and heat pain sensitivity in humans. Journal of Medical Genetics, 43(8), e40. PubMedCrossRef Kim, H., Mittal, D. P., Iadarola, M. J., & Dionne, R. A. (2006). Genetic predictors for acute experimental cold and heat pain sensitivity in humans. Journal of Medical Genetics, 43(8), e40. PubMedCrossRef
30.
go back to reference Caterina, M. J., Schumacher, M. A., Tominaga, M., Rosen, T. A., Levine, J. D., & Julius, D. (1997). The capsaicin receptor: A heat-activated ion channel in the pain pathway. Nature, 389(6653), 816–824. PubMedCrossRef Caterina, M. J., Schumacher, M. A., Tominaga, M., Rosen, T. A., Levine, J. D., & Julius, D. (1997). The capsaicin receptor: A heat-activated ion channel in the pain pathway. Nature, 389(6653), 816–824. PubMedCrossRef
31.
go back to reference Kim, H., Neubert, J. K., San Miguel, A., Xu, K., Krishnaraju, R. K., Iadarola, M. J., et al. (2004). Genetic influence on variability in human acute experimental pain sensitivity associated with gender, ethnicity and psychological temperament. Pain, 109(3), 488–496. PubMedCrossRef Kim, H., Neubert, J. K., San Miguel, A., Xu, K., Krishnaraju, R. K., Iadarola, M. J., et al. (2004). Genetic influence on variability in human acute experimental pain sensitivity associated with gender, ethnicity and psychological temperament. Pain, 109(3), 488–496. PubMedCrossRef
32.
go back to reference Lichtman, A. H., Shelton, C. C., Advani, T., & Cravatt, B. F. (2004). Mice lacking fatty acid amide hydrolase exhibit a cannabinoid receptor-mediated phenotypic hypoalgesia. Pain, 109(3), 319–327. PubMedCrossRef Lichtman, A. H., Shelton, C. C., Advani, T., & Cravatt, B. F. (2004). Mice lacking fatty acid amide hydrolase exhibit a cannabinoid receptor-mediated phenotypic hypoalgesia. Pain, 109(3), 319–327. PubMedCrossRef
33.
go back to reference Chiang, K. P., Gerber, A. L., Sipe, J. C., & Cravatt, B. F. (2004). Reduced cellular expression and activity of the P129T mutant of human fatty acid amide hydrolase: Evidence for a link between defects in the endocannabinoid system and problem drug use. Human Molecular Genetics, 13(18), 2113–2119. PubMedCrossRef Chiang, K. P., Gerber, A. L., Sipe, J. C., & Cravatt, B. F. (2004). Reduced cellular expression and activity of the P129T mutant of human fatty acid amide hydrolase: Evidence for a link between defects in the endocannabinoid system and problem drug use. Human Molecular Genetics, 13(18), 2113–2119. PubMedCrossRef
34.
go back to reference Raimondi, S., Sera, F., Gandini, S., Iodice, S., Caini, S., Maisonneuve, P., et al. (2008). MC1R variants, melanoma and red hair color phenotype: A meta-analysis. International Journal of Cancer, 122(12), 2753–2760. CrossRef Raimondi, S., Sera, F., Gandini, S., Iodice, S., Caini, S., Maisonneuve, P., et al. (2008). MC1R variants, melanoma and red hair color phenotype: A meta-analysis. International Journal of Cancer, 122(12), 2753–2760. CrossRef
35.
go back to reference Liem, E. B., Joiner, T. V., Tsueda, K., & Sessler, D. I. (2005). Increased sensitivity to thermal pain and reduced subcutaneous lidocaine efficacy in redheads. Anesthesiology, 102(3), 509–514. PubMedCrossRef Liem, E. B., Joiner, T. V., Tsueda, K., & Sessler, D. I. (2005). Increased sensitivity to thermal pain and reduced subcutaneous lidocaine efficacy in redheads. Anesthesiology, 102(3), 509–514. PubMedCrossRef
36.
go back to reference Mogil, J. S., Wilson, S. G., Chesler, E. J., Rankin, A. L., Nemmani, K. V., Lariviere, W. R., et al. (2003). The melanocortin-1 receptor gene mediates female-specific mechanisms of analgesia in mice and humans. Proceedings of the National Academy of Sciences of the United States of America, 100(8), 4867–4872. PubMedCrossRef Mogil, J. S., Wilson, S. G., Chesler, E. J., Rankin, A. L., Nemmani, K. V., Lariviere, W. R., et al. (2003). The melanocortin-1 receptor gene mediates female-specific mechanisms of analgesia in mice and humans. Proceedings of the National Academy of Sciences of the United States of America, 100(8), 4867–4872. PubMedCrossRef
37.
go back to reference Mogil, J. S., Ritchie, J., Smith, S. B., Strasburg, K., Kaplan, L., Wallace, M. R., et al. (2005). Melanocortin-1 receptor gene variants affect pain and mu-opioid analgesia in mice and humans. Journal of Medical Genetics, 42(7), 583–587. PubMedCrossRef Mogil, J. S., Ritchie, J., Smith, S. B., Strasburg, K., Kaplan, L., Wallace, M. R., et al. (2005). Melanocortin-1 receptor gene variants affect pain and mu-opioid analgesia in mice and humans. Journal of Medical Genetics, 42(7), 583–587. PubMedCrossRef
38.
go back to reference Lee, B. N., Dantzer, R., Langley, K. E., Bennett, G. J., Dougherty, P. M., Dunn, A. J., et al. (2004). A cytokine-based neuroimmunologic mechanism of cancer-related symptoms. Neuroimmunomodulation, 11(5), 279–292. PubMedCrossRef Lee, B. N., Dantzer, R., Langley, K. E., Bennett, G. J., Dougherty, P. M., Dunn, A. J., et al. (2004). A cytokine-based neuroimmunologic mechanism of cancer-related symptoms. Neuroimmunomodulation, 11(5), 279–292. PubMedCrossRef
39.
go back to reference Maier, S. F., & Watkins, L. R. (2003). Immune-to-central nervous system communication and its role in modulating pain and cognition: Implications for cancer and cancer treatment. Brain, Behavior, and Immunity, 17(Suppl 1), S125–S131. PubMedCrossRef Maier, S. F., & Watkins, L. R. (2003). Immune-to-central nervous system communication and its role in modulating pain and cognition: Implications for cancer and cancer treatment. Brain, Behavior, and Immunity, 17(Suppl 1), S125–S131. PubMedCrossRef
40.
go back to reference Oh, S. B., Tran, P. B., Gillard, S. E., Hurley, R. W., Hammond, D. L., & Miller, R. J. (2001). Chemokines and glycoprotein120 produce pain hypersensitivity by directly exciting primary nociceptive neurons. Journal of Neuroscience, 21(14), 5027–5035. PubMed Oh, S. B., Tran, P. B., Gillard, S. E., Hurley, R. W., Hammond, D. L., & Miller, R. J. (2001). Chemokines and glycoprotein120 produce pain hypersensitivity by directly exciting primary nociceptive neurons. Journal of Neuroscience, 21(14), 5027–5035. PubMed
41.
go back to reference Bennett, G. J., & Xie, Y. K. (1988). A peripheral mononeuropathy in rat that produces disorders of pain sensation like those seen in man. Pain, 33(1), 87–107. PubMedCrossRef Bennett, G. J., & Xie, Y. K. (1988). A peripheral mononeuropathy in rat that produces disorders of pain sensation like those seen in man. Pain, 33(1), 87–107. PubMedCrossRef
42.
go back to reference Bennett, G. J. (1999). Does a neuroimmune interaction contribute to the genesis of painful peripheral neuropathies? Proceedings of the National Academy of Sciences of the United States of America, 96(14), 7737–7738. PubMedCrossRef Bennett, G. J. (1999). Does a neuroimmune interaction contribute to the genesis of painful peripheral neuropathies? Proceedings of the National Academy of Sciences of the United States of America, 96(14), 7737–7738. PubMedCrossRef
43.
go back to reference Bennett, G. J. (2000). A neuroimmune interaction in painful peripheral neuropathy. Clinical Journal of Pain, 16(3 Suppl), S139–S143. PubMed Bennett, G. J. (2000). A neuroimmune interaction in painful peripheral neuropathy. Clinical Journal of Pain, 16(3 Suppl), S139–S143. PubMed
44.
go back to reference Reeve, A. J., Patel, S., Fox, A., Walker, K., & Urban, L. (2000). Intrathecally administered endotoxin or cytokines produce allodynia, hyperalgesia and changes in spinal cord neuronal responses to nociceptive stimuli in the rat. European Journal of Pain: Ejp, 4(3), 247–257. PubMedCrossRef Reeve, A. J., Patel, S., Fox, A., Walker, K., & Urban, L. (2000). Intrathecally administered endotoxin or cytokines produce allodynia, hyperalgesia and changes in spinal cord neuronal responses to nociceptive stimuli in the rat. European Journal of Pain: Ejp, 4(3), 247–257. PubMedCrossRef
45.
go back to reference Sommer, C., Petrausch, S., Lindenlaub, T., & Toyka, K. V. (1999). Neutralizing antibodies to interleukin 1-receptor reduce pain associated behavior in mice with experimental neuropathy. Neuroscience Letters, 270(1), 25–28. PubMedCrossRef Sommer, C., Petrausch, S., Lindenlaub, T., & Toyka, K. V. (1999). Neutralizing antibodies to interleukin 1-receptor reduce pain associated behavior in mice with experimental neuropathy. Neuroscience Letters, 270(1), 25–28. PubMedCrossRef
46.
go back to reference Dominici, R., Cattaneo, M., Malferrari, G., Archi, D., Mariani, C., Grimaldi, L. M., et al. (2002). Cloning and functional analysis of the allelic polymorphism in the transcription regulatory region of interleukin-1 alpha. Immunogenetics, 54(2), 82–86. PubMedCrossRef Dominici, R., Cattaneo, M., Malferrari, G., Archi, D., Mariani, C., Grimaldi, L. M., et al. (2002). Cloning and functional analysis of the allelic polymorphism in the transcription regulatory region of interleukin-1 alpha. Immunogenetics, 54(2), 82–86. PubMedCrossRef
47.
go back to reference Hulkkonen, J., Laippala, P., & Hurme, M. (2000). A rare allele combination of the interleukin-1 gene complex is associated with high interleukin-1 beta plasma levels in healthy individuals. European Cytokine Network, 11(2), 251–255. PubMed Hulkkonen, J., Laippala, P., & Hurme, M. (2000). A rare allele combination of the interleukin-1 gene complex is associated with high interleukin-1 beta plasma levels in healthy individuals. European Cytokine Network, 11(2), 251–255. PubMed
48.
go back to reference McDowell, T. L., Symons, J. A., Ploski, R., Førre, O., & Duff, G. W. (1995). A genetic association between juvenile rheumatoid arthritis and a novel interleukin-1 alpha polymorphism. Arthritis and Rheumatism, 38(2), 221–228. PubMedCrossRef McDowell, T. L., Symons, J. A., Ploski, R., Førre, O., & Duff, G. W. (1995). A genetic association between juvenile rheumatoid arthritis and a novel interleukin-1 alpha polymorphism. Arthritis and Rheumatism, 38(2), 221–228. PubMedCrossRef
49.
go back to reference Pociot, F., Mølvig, J., Wogensen, L., Worsaae, H., & Nerup, J. (1992). A TaqI polymorphism in the human interleukin-1 beta (IL-1 beta) gene correlates with IL-1 beta secretion in vitro. European Journal of Clinical Investigation, 22(6), 396–402. PubMedCrossRef Pociot, F., Mølvig, J., Wogensen, L., Worsaae, H., & Nerup, J. (1992). A TaqI polymorphism in the human interleukin-1 beta (IL-1 beta) gene correlates with IL-1 beta secretion in vitro. European Journal of Clinical Investigation, 22(6), 396–402. PubMedCrossRef
50.
go back to reference di Giovine, F. S., Takhsh, E., Blakemore, A. I., & Duff, G. W. (1992). Single base polymorphism at -511 in the human interleukin-1 beta gene (IL1 beta). Human Molecular Genetics, 1(6), 450. PubMedCrossRef di Giovine, F. S., Takhsh, E., Blakemore, A. I., & Duff, G. W. (1992). Single base polymorphism at -511 in the human interleukin-1 beta gene (IL1 beta). Human Molecular Genetics, 1(6), 450. PubMedCrossRef
51.
go back to reference Tarlow, J. K., Blakemore, A. I., Lennard, A., Solari, R., Hughes, H. N., Steinkasserer, A., et al. (1993). Polymorphism in human IL-1 receptor antagonist gene intron 2 is caused by variable numbers of an 86-bp tandem repeat. Human Genetics, 91(4), 403–404. PubMedCrossRef Tarlow, J. K., Blakemore, A. I., Lennard, A., Solari, R., Hughes, H. N., Steinkasserer, A., et al. (1993). Polymorphism in human IL-1 receptor antagonist gene intron 2 is caused by variable numbers of an 86-bp tandem repeat. Human Genetics, 91(4), 403–404. PubMedCrossRef
52.
go back to reference Tountas, N. A., Casini-Raggi, V., Yang, H., di Giovine, F. S., Vecchi, M., Kam, L., et al. (1999). Functional and ethnic association of allele 2 of the interleukin-1 receptor antagonist gene in ulcerative colitis. Gastroenterology, 117(4), 806–813. PubMedCrossRef Tountas, N. A., Casini-Raggi, V., Yang, H., di Giovine, F. S., Vecchi, M., Kam, L., et al. (1999). Functional and ethnic association of allele 2 of the interleukin-1 receptor antagonist gene in ulcerative colitis. Gastroenterology, 117(4), 806–813. PubMedCrossRef
53.
go back to reference Solovieva, S., Leino-Arjas, P., Saarela, J., Luoma, K., Raininko, R., & Riihimäki, H. (2004). Possible association of interleukin 1 gene locus polymorphisms with low back pain. Pain, 109(1–2), 8–19. PubMedCrossRef Solovieva, S., Leino-Arjas, P., Saarela, J., Luoma, K., Raininko, R., & Riihimäki, H. (2004). Possible association of interleukin 1 gene locus polymorphisms with low back pain. Pain, 109(1–2), 8–19. PubMedCrossRef
54.
go back to reference Bessler, H., Shavit, Y., Mayburd, E., Smirnov, G., & Beilin, B. (2006). Postoperative pain, morphine consumption, and genetic polymorphism of IL-1 beta and IL-1 receptor antagonist. Neuroscience Letters, 404(1–2), 154–158. PubMedCrossRef Bessler, H., Shavit, Y., Mayburd, E., Smirnov, G., & Beilin, B. (2006). Postoperative pain, morphine consumption, and genetic polymorphism of IL-1 beta and IL-1 receptor antagonist. Neuroscience Letters, 404(1–2), 154–158. PubMedCrossRef
55.
go back to reference Winkelstein, B. A., Rutkowski, M. D., Weinstein, J. N., & DeLeo, J. A. (2001). Quantification of neural tissue injury in a rat radiculopathy model: Comparison of local deformation, behavioral outcomes, and spinal cytokine mRNA for two surgeons. Journal of Neuroscience Methods, 111(1), 49–57. PubMedCrossRef Winkelstein, B. A., Rutkowski, M. D., Weinstein, J. N., & DeLeo, J. A. (2001). Quantification of neural tissue injury in a rat radiculopathy model: Comparison of local deformation, behavioral outcomes, and spinal cytokine mRNA for two surgeons. Journal of Neuroscience Methods, 111(1), 49–57. PubMedCrossRef
56.
go back to reference Bianchi, M., Maggi, R., Pimpinelli, F., Rubino, T., Parolaro, D., Poli, V., et al. (1999). Presence of a reduced opioid response in interleukin-6 knock out mice. European Journal of Neuroscience, 11(5), 1501–1507. PubMedCrossRef Bianchi, M., Maggi, R., Pimpinelli, F., Rubino, T., Parolaro, D., Poli, V., et al. (1999). Presence of a reduced opioid response in interleukin-6 knock out mice. European Journal of Neuroscience, 11(5), 1501–1507. PubMedCrossRef
57.
go back to reference Wang, X. S., Shi, Q., Williams, L. A., Cleeland, C. S., Mobley, G. M., Reuben, J. M., et al. (2008). Serum interleukin-6 predicts the development of multiple symptoms at nadir of allogeneic hematopoietic stem cell transplantation. Cancer, 113(8), 2102–2109. PubMedCrossRef Wang, X. S., Shi, Q., Williams, L. A., Cleeland, C. S., Mobley, G. M., Reuben, J. M., et al. (2008). Serum interleukin-6 predicts the development of multiple symptoms at nadir of allogeneic hematopoietic stem cell transplantation. Cancer, 113(8), 2102–2109. PubMedCrossRef
58.
go back to reference Fishman, D., Faulds, G., Jeffery, R., Mohamed-Ali, V., Yudkin, J. S., Humphries, S., et al. (1998). The effect of novel polymorphisms in the interleukin-6 (IL-6) gene on IL-6 transcription and plasma IL-6 levels, and an association with systemic-onset juvenile chronic arthritis. Journal of Clinical Investigation, 102(7), 1369–1376. PubMedCrossRef Fishman, D., Faulds, G., Jeffery, R., Mohamed-Ali, V., Yudkin, J. S., Humphries, S., et al. (1998). The effect of novel polymorphisms in the interleukin-6 (IL-6) gene on IL-6 transcription and plasma IL-6 levels, and an association with systemic-onset juvenile chronic arthritis. Journal of Clinical Investigation, 102(7), 1369–1376. PubMedCrossRef
59.
go back to reference Reyes-Gibby, C. C., El Osta, B., Spitz, M. R., Parsons, H., Kurzrock, R., Wu, X., et al. (2008). The influence of tumor necrosis factor-alpha -308 G/A and IL-6–174 G/C on pain and analgesia response in lung cancer patients receiving supportive care. Cancer Epidemiology, Biomarkers and Prevention, 17(11), 3262–3267. PubMedCrossRef Reyes-Gibby, C. C., El Osta, B., Spitz, M. R., Parsons, H., Kurzrock, R., Wu, X., et al. (2008). The influence of tumor necrosis factor-alpha -308 G/A and IL-6–174 G/C on pain and analgesia response in lung cancer patients receiving supportive care. Cancer Epidemiology, Biomarkers and Prevention, 17(11), 3262–3267. PubMedCrossRef
60.
go back to reference Oen, K., Malleson, P. N., Cabral, D. A., Rosenberg, A. M., Petty, R. E., Nickerson, P., et al. (2005). Cytokine genotypes correlate with pain and radiologically defined joint damage in patients with juvenile rheumatoid arthritis. Rheumatology (Oxford), 44(9), 1115–1121. CrossRef Oen, K., Malleson, P. N., Cabral, D. A., Rosenberg, A. M., Petty, R. E., Nickerson, P., et al. (2005). Cytokine genotypes correlate with pain and radiologically defined joint damage in patients with juvenile rheumatoid arthritis. Rheumatology (Oxford), 44(9), 1115–1121. CrossRef
61.
go back to reference Karppinen, J., Daavittila, I., Noponen, N., Haapea, M., Taimela, S., Vanharanta, H., et al. (2008). Is the interleukin-6 haplotype a prognostic factor for sciatica? European Journal of Pain: Ejp, 12(8), 1018–1025. PubMedCrossRef Karppinen, J., Daavittila, I., Noponen, N., Haapea, M., Taimela, S., Vanharanta, H., et al. (2008). Is the interleukin-6 haplotype a prognostic factor for sciatica? European Journal of Pain: Ejp, 12(8), 1018–1025. PubMedCrossRef
62.
go back to reference Utreras, E., Futatsugi, A., Rudrabhatla, P., Keller, J., Iadarola, M. J., Pant, H. C., et al. (2009). Tumor necrosis factor-alpha regulates cyclin-dependent kinase 5 activity during pain signaling through transcriptional activation of p35. The Journal of Biological Chemistry, 284(4), 2275–2284. PubMedCrossRef Utreras, E., Futatsugi, A., Rudrabhatla, P., Keller, J., Iadarola, M. J., Pant, H. C., et al. (2009). Tumor necrosis factor-alpha regulates cyclin-dependent kinase 5 activity during pain signaling through transcriptional activation of p35. The Journal of Biological Chemistry, 284(4), 2275–2284. PubMedCrossRef
63.
go back to reference Segond von Banchet, G., Boettger, M. K., Fischer, N., Gajda, M., Bräuer, R., & Schaible, H. G. (2009). Experimental arthritis causes tumor necrosis factor-alpha-dependent infiltration of macrophages into rat dorsal root ganglia which correlates with pain-related behavior. Pain, 145(1–2), 151–159. PubMedCrossRef Segond von Banchet, G., Boettger, M. K., Fischer, N., Gajda, M., Bräuer, R., & Schaible, H. G. (2009). Experimental arthritis causes tumor necrosis factor-alpha-dependent infiltration of macrophages into rat dorsal root ganglia which correlates with pain-related behavior. Pain, 145(1–2), 151–159. PubMedCrossRef
64.
go back to reference Wilson, A. G., Symons, J. A., McDowell, T. L., McDevitt, H. O., & Duff, G. W. (1997). Effects of a polymorphism in the human tumor necrosis factor alpha promoter on transcriptional activation. Proceedings of the National Academy of Sciences of the United States of America, 94(7), 3195–3199. PubMedCrossRef Wilson, A. G., Symons, J. A., McDowell, T. L., McDevitt, H. O., & Duff, G. W. (1997). Effects of a polymorphism in the human tumor necrosis factor alpha promoter on transcriptional activation. Proceedings of the National Academy of Sciences of the United States of America, 94(7), 3195–3199. PubMedCrossRef
65.
go back to reference Ahn, S. H., Cho, Y. W., Ahn, M. W., Jang, S. H., Sohn, Y. K., & Kim, H. S. (2002). mRNA expression of cytokines and chemokines in herniated lumbar intervertebral discs. Spine (Phila Pa 1976), 27(9), 911–917. Ahn, S. H., Cho, Y. W., Ahn, M. W., Jang, S. H., Sohn, Y. K., & Kim, H. S. (2002). mRNA expression of cytokines and chemokines in herniated lumbar intervertebral discs. Spine (Phila Pa 1976), 27(9), 911–917.
66.
go back to reference Wang, X. M., Hamza, M., Wu, T. X., & Dionne, R. A. (2009). Upregulation of IL-6, IL-8 and CCL2 gene expression after acute inflammation: Correlation to clinical pain. Pain, 142(3), 275–283. PubMedCrossRef Wang, X. M., Hamza, M., Wu, T. X., & Dionne, R. A. (2009). Upregulation of IL-6, IL-8 and CCL2 gene expression after acute inflammation: Correlation to clinical pain. Pain, 142(3), 275–283. PubMedCrossRef
67.
go back to reference Hull, J., Thomson, A., & Kwiatkowski, D. (2000). Association of respiratory syncytial virus bronchiolitis with the interleukin 8 gene region in UK families. Thorax, 55(12), 1023–1027. PubMedCrossRef Hull, J., Thomson, A., & Kwiatkowski, D. (2000). Association of respiratory syncytial virus bronchiolitis with the interleukin 8 gene region in UK families. Thorax, 55(12), 1023–1027. PubMedCrossRef
68.
go back to reference Reyes-Gibby, C. C., Spitz, M., Wu, X., Merriman, K., Etzel, C., Bruera, E., et al. (2007). Cytokine genes and pain severity in lung cancer: Exploring the influence of TNF-alpha-308 G/A IL6–174G/C and IL8–251T/A. Cancer Epidemiology, Biomarkers and Prevention, 16(12), 2745–2751. PubMedCrossRef Reyes-Gibby, C. C., Spitz, M., Wu, X., Merriman, K., Etzel, C., Bruera, E., et al. (2007). Cytokine genes and pain severity in lung cancer: Exploring the influence of TNF-alpha-308 G/A IL6–174G/C and IL8–251T/A. Cancer Epidemiology, Biomarkers and Prevention, 16(12), 2745–2751. PubMedCrossRef
69.
go back to reference Schinkel, A. H., Wagenaar, E., van Deemter, L., Mol, C. A., & Borst, P. (1995). Absence of the mdr1a P-Glycoprotein in mice affects tissue distribution and pharmacokinetics of dexamethasone, digoxin, and cyclosporin A. Journal of Clinical Investigation, 96(4), 1698–1705. PubMedCrossRef Schinkel, A. H., Wagenaar, E., van Deemter, L., Mol, C. A., & Borst, P. (1995). Absence of the mdr1a P-Glycoprotein in mice affects tissue distribution and pharmacokinetics of dexamethasone, digoxin, and cyclosporin A. Journal of Clinical Investigation, 96(4), 1698–1705. PubMedCrossRef
70.
go back to reference Thompson, S. J., Koszdin, K., & Bernards, C. M. (2000). Opiate-induced analgesia is increased and prolonged in mice lacking P-glycoprotein. Anesthesiology, 92(5), 1392–1399. PubMedCrossRef Thompson, S. J., Koszdin, K., & Bernards, C. M. (2000). Opiate-induced analgesia is increased and prolonged in mice lacking P-glycoprotein. Anesthesiology, 92(5), 1392–1399. PubMedCrossRef
71.
go back to reference King, M., Su, W., Chang, A., Zuckerman, A., & Pasternak, G. W. (2001). Transport of opioids from the brain to the periphery by P-glycoprotein: Peripheral actions of central drugs. Nature Neuroscience, 4(3), 268–274. PubMedCrossRef King, M., Su, W., Chang, A., Zuckerman, A., & Pasternak, G. W. (2001). Transport of opioids from the brain to the periphery by P-glycoprotein: Peripheral actions of central drugs. Nature Neuroscience, 4(3), 268–274. PubMedCrossRef
72.
go back to reference Higgins, C. F. (2001). ABC transporters: Physiology, structure and mechanism–an overview. Research in Microbiology, 152(3–4), 205–210. PubMedCrossRef Higgins, C. F. (2001). ABC transporters: Physiology, structure and mechanism–an overview. Research in Microbiology, 152(3–4), 205–210. PubMedCrossRef
73.
go back to reference Hoffmeyer, S., Burk, O., von Richter, O., Arnold, H. P., Brockmöller, J., Johne, A., et al. (2000). Functional polymorphisms of the human multidrug-resistance gene: Multiple sequence variations and correlation of one allele with P-glycoprotein expression and activity in vivo. Proceedings of the National Academy of Sciences of the United States of America, 97(7), 3473–3478. PubMedCrossRef Hoffmeyer, S., Burk, O., von Richter, O., Arnold, H. P., Brockmöller, J., Johne, A., et al. (2000). Functional polymorphisms of the human multidrug-resistance gene: Multiple sequence variations and correlation of one allele with P-glycoprotein expression and activity in vivo. Proceedings of the National Academy of Sciences of the United States of America, 97(7), 3473–3478. PubMedCrossRef
74.
go back to reference Lötsch, J., von Hentig, N., Freynhagen, R., Griessinger, N., Zimmermann, M., Doehring, A., et al. (2009). Cross-sectional analysis of the influence of currently known pharmacogenetic modulators on opioid therapy in outpatient pain centers. Pharmacogenetics and genomics, 19(6), 429–436. PubMedCrossRef Lötsch, J., von Hentig, N., Freynhagen, R., Griessinger, N., Zimmermann, M., Doehring, A., et al. (2009). Cross-sectional analysis of the influence of currently known pharmacogenetic modulators on opioid therapy in outpatient pain centers. Pharmacogenetics and genomics, 19(6), 429–436. PubMedCrossRef
75.
go back to reference Campa, D., Gioia, A., Tomei, A., Poli, P., & Barale, R. (2008). Association of ABCB1/MDR1 and OPRM1 gene polymorphisms with morphine pain relief. Clinical Pharmacology and Therapeutics, 83(4), 559–566. PubMedCrossRef Campa, D., Gioia, A., Tomei, A., Poli, P., & Barale, R. (2008). Association of ABCB1/MDR1 and OPRM1 gene polymorphisms with morphine pain relief. Clinical Pharmacology and Therapeutics, 83(4), 559–566. PubMedCrossRef
76.
go back to reference Coller, J. K., Barratt, D. T., Dahlen, K., Loennechen, M. H., & Somogyi, A. A. (2006). ABCB1 genetic variability and methadone dosage requirements in opioid-dependent individuals. Clinical Pharmacology and Therapeutics, 80(6), 682–690. PubMedCrossRef Coller, J. K., Barratt, D. T., Dahlen, K., Loennechen, M. H., & Somogyi, A. A. (2006). ABCB1 genetic variability and methadone dosage requirements in opioid-dependent individuals. Clinical Pharmacology and Therapeutics, 80(6), 682–690. PubMedCrossRef
77.
go back to reference Park, H. J., Shinn, H. K., Ryu, S. H., Lee, H. S., Park, C. S., & Kang, J. H. (2007). Genetic polymorphisms in the ABCB1 gene and the effects of fentanyl in Koreans. Clinical Pharmacology and Therapeutics, 81(4), 539–546. PubMedCrossRef Park, H. J., Shinn, H. K., Ryu, S. H., Lee, H. S., Park, C. S., & Kang, J. H. (2007). Genetic polymorphisms in the ABCB1 gene and the effects of fentanyl in Koreans. Clinical Pharmacology and Therapeutics, 81(4), 539–546. PubMedCrossRef
78.
go back to reference Guengerich, F. P. (2008). Cytochrome p450 and chemical toxicology. Chemical Research in Toxicology, 21(1), 70–83. PubMedCrossRef Guengerich, F. P. (2008). Cytochrome p450 and chemical toxicology. Chemical Research in Toxicology, 21(1), 70–83. PubMedCrossRef
79.
go back to reference Stamer, U. M., Musshoff, F., Kobilay, M., Madea, B., Hoeft, A., & Stuber, F. (2007). Concentrations of tramadol and O-desmethyltramadol enantiomers in different CYP2D6 genotypes. Clinical Pharmacology and Therapeutics, 82(1), 41–47. PubMedCrossRef Stamer, U. M., Musshoff, F., Kobilay, M., Madea, B., Hoeft, A., & Stuber, F. (2007). Concentrations of tramadol and O-desmethyltramadol enantiomers in different CYP2D6 genotypes. Clinical Pharmacology and Therapeutics, 82(1), 41–47. PubMedCrossRef
80.
go back to reference Zanger, U. M., Klein, K., Saussele, T., Blievernicht, J., Hofmann, M. H., & Schwab, M. (2007). Polymorphic CYP2B6: Molecular mechanisms and emerging clinical significance. Pharmacogenomics, 8(7), 743–759. PubMedCrossRef Zanger, U. M., Klein, K., Saussele, T., Blievernicht, J., Hofmann, M. H., & Schwab, M. (2007). Polymorphic CYP2B6: Molecular mechanisms and emerging clinical significance. Pharmacogenomics, 8(7), 743–759. PubMedCrossRef
81.
go back to reference Paar, W. D., Poche, S., Gerloff, J., & Dengler, H. J. (1997). Polymorphic CYP2D6 mediates O-demethylation of the opioid analgesic tramadol. European Journal of Clinical Pharmacology, 53(3–4), 235–239. PubMedCrossRef Paar, W. D., Poche, S., Gerloff, J., & Dengler, H. J. (1997). Polymorphic CYP2D6 mediates O-demethylation of the opioid analgesic tramadol. European Journal of Clinical Pharmacology, 53(3–4), 235–239. PubMedCrossRef
82.
go back to reference de Leon, J., Susce, M. T., & Murray-Carmichael, E. (2006). The AmpliChip CYP450 genotyping test: Integrating a new clinical tool. Molecular diagnosis & therapy, 10(3), 135–151. de Leon, J., Susce, M. T., & Murray-Carmichael, E. (2006). The AmpliChip CYP450 genotyping test: Integrating a new clinical tool. Molecular diagnosis & therapy, 10(3), 135–151.
83.
go back to reference Desmeules, J., Gascon, M. P., Dayer, P., & Magistris, M. (1991). Impact of environmental and genetic factors on codeine analgesia. European Journal of Clinical Pharmacology, 41(1), 23–26. PubMedCrossRef Desmeules, J., Gascon, M. P., Dayer, P., & Magistris, M. (1991). Impact of environmental and genetic factors on codeine analgesia. European Journal of Clinical Pharmacology, 41(1), 23–26. PubMedCrossRef
84.
go back to reference Yue, Q. Y., Hasselström, J., Svensson, J. O., & Säwe, J. (1991). Pharmacokinetics of codeine and its metabolites in Caucasian healthy volunteers: Comparisons between extensive and poor hydroxylators of debrisoquine. British Journal of Clinical Pharmacology, 31(6), 635–642. PubMed Yue, Q. Y., Hasselström, J., Svensson, J. O., & Säwe, J. (1991). Pharmacokinetics of codeine and its metabolites in Caucasian healthy volunteers: Comparisons between extensive and poor hydroxylators of debrisoquine. British Journal of Clinical Pharmacology, 31(6), 635–642. PubMed
85.
go back to reference Wang, G., Zhang, H., He, F., & Fang, X. (2006). Effect of the CYP2D6*10 C188T polymorphism on postoperative tramadol analgesia in a Chinese population. European Journal of Clinical Pharmacology, 62(11), 927–931. PubMedCrossRef Wang, G., Zhang, H., He, F., & Fang, X. (2006). Effect of the CYP2D6*10 C188T polymorphism on postoperative tramadol analgesia in a Chinese population. European Journal of Clinical Pharmacology, 62(11), 927–931. PubMedCrossRef
86.
go back to reference Crettol, S., Déglon, J. J., Besson, J., Croquette-Krokar, M., Hämmig, R., Gothuey, I., et al. (2006). ABCB1 and cytochrome P450 genotypes and phenotypes: Influence on methadone plasma levels and response to treatment. Clinical Pharmacology and Therapeutics, 80(6), 668–681. PubMedCrossRef Crettol, S., Déglon, J. J., Besson, J., Croquette-Krokar, M., Hämmig, R., Gothuey, I., et al. (2006). ABCB1 and cytochrome P450 genotypes and phenotypes: Influence on methadone plasma levels and response to treatment. Clinical Pharmacology and Therapeutics, 80(6), 668–681. PubMedCrossRef
87.
go back to reference Pilotto, A., Seripa, D., Franceschi, M., Scarcelli, C., Colaizzo, D., Grandone, E., et al. (2007). Genetic susceptibility to nonsteroidal anti-inflammatory drug-related gastroduodenal bleeding: Role of cytochrome P450 2C9 polymorphisms. Gastroenterology, 133(2), 465–471. PubMedCrossRef Pilotto, A., Seripa, D., Franceschi, M., Scarcelli, C., Colaizzo, D., Grandone, E., et al. (2007). Genetic susceptibility to nonsteroidal anti-inflammatory drug-related gastroduodenal bleeding: Role of cytochrome P450 2C9 polymorphisms. Gastroenterology, 133(2), 465–471. PubMedCrossRef
88.
go back to reference Armstrong, S. C., & Cozza, K. L. (2003). Pharmacokinetic drug interactions of morphine, codeine, and their derivatives: Theory and clinical reality, part I. Psychosomatics, 44(2), 167–171. PubMedCrossRef Armstrong, S. C., & Cozza, K. L. (2003). Pharmacokinetic drug interactions of morphine, codeine, and their derivatives: Theory and clinical reality, part I. Psychosomatics, 44(2), 167–171. PubMedCrossRef
89.
go back to reference Holthe, M., Rakvåg, T. N., Klepstad, P., Idle, J. R., Kaasa, S., Krokan, H. E., et al. (2003). Sequence variations in the UDP-glucuronosyltransferase 2B7 (UGT2B7) gene: Identification of 10 novel single nucleotide polymorphisms (SNPs) and analysis of their relevance to morphine glucuronidation in cancer patients. The Pharmacogenomics Journal, 3(1), 17–26. PubMedCrossRef Holthe, M., Rakvåg, T. N., Klepstad, P., Idle, J. R., Kaasa, S., Krokan, H. E., et al. (2003). Sequence variations in the UDP-glucuronosyltransferase 2B7 (UGT2B7) gene: Identification of 10 novel single nucleotide polymorphisms (SNPs) and analysis of their relevance to morphine glucuronidation in cancer patients. The Pharmacogenomics Journal, 3(1), 17–26. PubMedCrossRef
90.
go back to reference Duguay, Y., Báár, C., Skorpen, F., & Guillemette, C. (2004). A novel functional polymorphism in the uridine diphosphate-glucuronosyltransferase 2B7 promoter with significant impact on promoter activity. Clinical Pharmacology and Therapeutics, 75(3), 223–233. PubMedCrossRef Duguay, Y., Báár, C., Skorpen, F., & Guillemette, C. (2004). A novel functional polymorphism in the uridine diphosphate-glucuronosyltransferase 2B7 promoter with significant impact on promoter activity. Clinical Pharmacology and Therapeutics, 75(3), 223–233. PubMedCrossRef
91.
go back to reference Darbari, D. S., van Schaik, R. H., Capparelli, E. V., Rana, S., McCarter, R., & van den Anker, J. (2008). UGT2B7 promoter variant -840G>A contributes to the variability in hepatic clearance of morphine in patients with sickle cell disease. American Journal of Hematology, 83(3), 200–202. PubMedCrossRef Darbari, D. S., van Schaik, R. H., Capparelli, E. V., Rana, S., McCarter, R., & van den Anker, J. (2008). UGT2B7 promoter variant -840G>A contributes to the variability in hepatic clearance of morphine in patients with sickle cell disease. American Journal of Hematology, 83(3), 200–202. PubMedCrossRef
92.
93.
go back to reference Rakvåg, T. T., Klepstad, P., Báár, C., Kvam, T. M., Dale, O., Kaasa, S., et al. (2005). The Val158Met polymorphism of the human catechol-O-methyltransferase (COMT) gene may influence morphine requirements in cancer pain patients. Pain, 116(1–2), 73–78. PubMedCrossRef Rakvåg, T. T., Klepstad, P., Báár, C., Kvam, T. M., Dale, O., Kaasa, S., et al. (2005). The Val158Met polymorphism of the human catechol-O-methyltransferase (COMT) gene may influence morphine requirements in cancer pain patients. Pain, 116(1–2), 73–78. PubMedCrossRef
94.
go back to reference Hagen, K., Pettersen, E., Stovner, L. J., Skorpen, F., & Zwart, J. A. (2006). The association between headache and Val158Met polymorphism in the catechol-O-methyltransferase gene: The HUNT Study. The Journal of Headache and Pain, 7(2), 70–74. PubMedCrossRef Hagen, K., Pettersen, E., Stovner, L. J., Skorpen, F., & Zwart, J. A. (2006). The association between headache and Val158Met polymorphism in the catechol-O-methyltransferase gene: The HUNT Study. The Journal of Headache and Pain, 7(2), 70–74. PubMedCrossRef
95.
go back to reference Vargas-Alarcón, G., Fragoso, J. M., Cruz-Robles, D., Vargas, A., Vargas, A., Lao-Villadóniga, J. I., et al. (2007). Catechol-O-methyltransferase gene haplotypes in Mexican and Spanish patients with fibromyalgia. Arthritis Research & Therapy, 9(5), R110. CrossRef Vargas-Alarcón, G., Fragoso, J. M., Cruz-Robles, D., Vargas, A., Vargas, A., Lao-Villadóniga, J. I., et al. (2007). Catechol-O-methyltransferase gene haplotypes in Mexican and Spanish patients with fibromyalgia. Arthritis Research & Therapy, 9(5), R110. CrossRef
96.
go back to reference Kim, H., Lee, H., Rowan, J., Brahim, J., & Dionne, R. A. (2006). Genetic polymorphisms in monoamine neurotransmitter systems show only weak association with acute post-surgical pain in humans. Molecular Pain, 2, 24. PubMedCrossRef Kim, H., Lee, H., Rowan, J., Brahim, J., & Dionne, R. A. (2006). Genetic polymorphisms in monoamine neurotransmitter systems show only weak association with acute post-surgical pain in humans. Molecular Pain, 2, 24. PubMedCrossRef
97.
go back to reference Ruaño, G., Thompson, P. D., Windemuth, A., Seip, R. L., Dande, A., Sorokin, A., et al. (2007). Physiogenomic association of statin-related myalgia to serotonin receptors. Muscle and Nerve, 36(3), 329–335. PubMedCrossRef Ruaño, G., Thompson, P. D., Windemuth, A., Seip, R. L., Dande, A., Sorokin, A., et al. (2007). Physiogenomic association of statin-related myalgia to serotonin receptors. Muscle and Nerve, 36(3), 329–335. PubMedCrossRef
98.
go back to reference Guimarães, A. L., Correia-Silva Jde, F., Sá, A. R., Victória, J. M., Diniz, M. G., Costa Fde, O., et al. (2007). Investigation of functional gene polymorphisms IL-1beta, IL-6, IL-10 and TNF-alpha in individuals with recurrent aphthous stomatitis. Archives of Oral Biology, 52(3), 268–272. PubMedCrossRef Guimarães, A. L., Correia-Silva Jde, F., Sá, A. R., Victória, J. M., Diniz, M. G., Costa Fde, O., et al. (2007). Investigation of functional gene polymorphisms IL-1beta, IL-6, IL-10 and TNF-alpha in individuals with recurrent aphthous stomatitis. Archives of Oral Biology, 52(3), 268–272. PubMedCrossRef
99.
go back to reference Klepstad, P., Dale, O., Skorpen, F., Borchgrevink, P. C., & Kaasa, S. (2005). Genetic variability and clinical efficacy of morphine. Acta Anaesthesiologica Scandinavica, 49(7), 902–908. PubMedCrossRef Klepstad, P., Dale, O., Skorpen, F., Borchgrevink, P. C., & Kaasa, S. (2005). Genetic variability and clinical efficacy of morphine. Acta Anaesthesiologica Scandinavica, 49(7), 902–908. PubMedCrossRef
100.
go back to reference Pedersen, R. S., Damkier, P., & Brosen, K. (2005). Tramadol as a new probe for cytochrome P450 2D6 phenotyping: A population study. Clinical Pharmacology and Therapeutics, 77(6), 458–467. PubMedCrossRef Pedersen, R. S., Damkier, P., & Brosen, K. (2005). Tramadol as a new probe for cytochrome P450 2D6 phenotyping: A population study. Clinical Pharmacology and Therapeutics, 77(6), 458–467. PubMedCrossRef
101.
go back to reference Coller, J. K., Joergensen, C., Foster, D. J., James, H., Gillis, D., Christrup, L., et al. (2007). Lack of influence of CYP2D6 genotype on the clearance of (R)-, (S)- and racemic-methadone. International Journal of Clinical Pharmacology and Therapeutics, 45(7), 410–417. PubMed Coller, J. K., Joergensen, C., Foster, D. J., James, H., Gillis, D., Christrup, L., et al. (2007). Lack of influence of CYP2D6 genotype on the clearance of (R)-, (S)- and racemic-methadone. International Journal of Clinical Pharmacology and Therapeutics, 45(7), 410–417. PubMed
102.
go back to reference Ferrari, A., Coccia, C. P., Bertolini, A., & Sternieri, E. (2004). Methadone–metabolism, pharmacokinetics and interactions. Pharmacological Research, 50(6), 551–559. PubMedCrossRef Ferrari, A., Coccia, C. P., Bertolini, A., & Sternieri, E. (2004). Methadone–metabolism, pharmacokinetics and interactions. Pharmacological Research, 50(6), 551–559. PubMedCrossRef
103.
go back to reference Shiran, M. R., Lennard, M. S., Iqbal, M. Z., Lagundoye, O., Seivewright, N., Tucker, G. T., et al. (2009). Contribution of the activities of CYP3A, CYP2D6, CYP1A2 and other potential covariates to the disposition of methadone in patients undergoing methadone maintenance treatment. British Journal of Clinical Pharmacology, 67(1), 29–37. PubMedCrossRef Shiran, M. R., Lennard, M. S., Iqbal, M. Z., Lagundoye, O., Seivewright, N., Tucker, G. T., et al. (2009). Contribution of the activities of CYP3A, CYP2D6, CYP1A2 and other potential covariates to the disposition of methadone in patients undergoing methadone maintenance treatment. British Journal of Clinical Pharmacology, 67(1), 29–37. PubMedCrossRef
104.
go back to reference Cai, W., Chen, B., Tao, X., Ling, S., & Zhang, Y. (2000). Correlation of genetic polymorphism of cytochrome P4502D6 with dextromethorphan oxidative metabolism in Chinese. Zhonghua Yixue Yichuanxue Zazhi, 17(3), 181–184. PubMed Cai, W., Chen, B., Tao, X., Ling, S., & Zhang, Y. (2000). Correlation of genetic polymorphism of cytochrome P4502D6 with dextromethorphan oxidative metabolism in Chinese. Zhonghua Yixue Yichuanxue Zazhi, 17(3), 181–184. PubMed
105.
go back to reference Takashima, T., Murase, S., Iwasaki, K., & Shimada, K. (2005). Evaluation of dextromethorphan metabolism using hepatocytes from CYP2D6 poor and extensive metabolizers. Drug Metabolism and Pharmacokinetics, 20(3), 177–182. PubMedCrossRef Takashima, T., Murase, S., Iwasaki, K., & Shimada, K. (2005). Evaluation of dextromethorphan metabolism using hepatocytes from CYP2D6 poor and extensive metabolizers. Drug Metabolism and Pharmacokinetics, 20(3), 177–182. PubMedCrossRef
Metagegevens
Titel
Biological pathways and genetic variables involved in pain
Auteurs
Qiuling Shi
Charles S. Cleeland
Pål Klepstad
Christine Miaskowski
Nancy L. Pedersen
Publicatiedatum
01-12-2010
Uitgeverij
Springer Netherlands
Gepubliceerd in
Quality of Life Research / Uitgave 10/2010
Print ISSN: 0962-9343
Elektronisch ISSN: 1573-2649
DOI
https://doi.org/10.1007/s11136-010-9738-x